Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial. (2018)
Attributed to:
CANCER: Trials with potential global reach and other challenging trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2017.12.017
PubMed Identifier: 29307509
Publication URI: http://europepmc.org/abstract/MED/29307509
Type: Journal Article/Review
Volume: 73
Parent Publication: European urology
Issue: 6
ISSN: 0302-2838